Hongbo Liu
Shijiazhuang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
HER2-low as a unique subgroup in breast cancer: insights from neoadjuvant chemotherapy response and survival analysis.
Journal: Journal of clinical pathology
Published: March 08, 2026
HER2 testing in multifocal/multicentric breast cancer: should all foci be tested in the context of HER2-low and HER2-ultralow?
Journal: Breast (Edinburgh, Scotland)
Published: May 14, 2025
CircATP5C1 promotes triple-negative breast cancer progression by binding IGF2BP2 to modulate CSF-1 secretion.
Journal: Cancer biology & therapy
Published: April 03, 2025
The impact of circWWC3 on neoadjuvant therapy for triple-negative breast cancer and the construction of a nomogram for predicting pathological complete response after neoadjuvant therapy.
Journal: Frontiers in oncology
Published: January 22, 2025
Artificial intelligence for assisted HER2 immunohistochemistry evaluation of breast cancer: A systematic review and meta-analysis.
Journal: Pathology, research and practice
Published: April 22, 2024
Tumour mutation burden and infiltrating immune cell subtypes influenced the breast cancer prognosis.
Tumour mutation burden and infiltrating immune cell subtypes influenced the breast cancer prognosis.
Journal: Translational cancer research
Published: November 29, 2023
Artificial intelligence enhances whole-slide interpretation of PD-L1 CPS in triple-negative breast cancer: A multi-institutional ring study.
Journal: Histopathology
Published: October 11, 2023
Prognostic factors of patients with human epidermal growth factor receptor 2-positive breast cancer following neoadjuvant therapy: Development and validation of a predictive nomogram.
Journal: Pathology, research and practice
Published: September 09, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026